EUVIMEDEUVIMED entdecken
Open Access

Scalable generation and functional classification of genetic variants in inborn errors of immunity to accelerate clinical diagnosis and treatment

Zachary H Walsh, Chris J Frangieh, Neeharika Kothapalli, Jay Levy, Clarissa K Heck, Johannes C Melms, Ron S Gejman, Parin Shah, Jared M Pollard, Akul Naik, Sarah L Grauman, Lei Haley Huang und 4 weitere

Cell · 2025

DOI: 10.1016/j.cell.2025.05.037 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell, 2025. Verfasst von Zachary H Walsh und 15 weiteren Autor:innen. Beteiligte Einrichtung: Columbia University Vagelos College of Physicians and Surgeons, New York, NY, USA; Department of Medicine, Division of Hematology and Oncology, Colum…. Hauptthemen laut MEDLINE: Class I Phosphatidylinositol 3-Kinases, Class Ia Phosphatidylinositol 3-Kinase, Primary Immunodeficiency Diseases, Genetic Variation. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 85 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIAID NIH HHS, NIGMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Next-generation sequencing is pivotal for diagnosing inborn errors of immunity (IEI) but predominantly yields variants of uncertain significance (VUS), creating clinical ambiguity. Activated PI3Kδ syndrome (APDS) is caused by gain-of-function (GOF) variants in PIK3CD or PIK3R1, which encode the PI3Kδ heterodimer. We performed massively parallel base editing of PIK3CD/PIK3R1 in human T cells and mapped thousands of variants to a clinically important readout (phospho-AKT/S6), nominating >100 VUS and unannotated variants for functional classification and validating 27 hits. Leniolisib, an FDA-approved PI3Kδ inhibitor, rescued aberrant signaling and dysfunction in GOF-harboring T cells and revealed partially drug-resistant PIK3R1 hotspots that responded to novel combination therapies of leniolisib with mTORC1/2 inhibition. We confirmed these findings in T cells from APDS patients spanning the functional spectrum discovered in the screen. Integrating our screens with population-level genomic studies revealed that APDS may be more prevalent than previously estimated. This work exemplifies a broadly applicable framework for removing ambiguity from sequencing in IEI.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Class I Phosphatidylinositol 3-KinasesClass Ia Phosphatidylinositol 3-KinasePrimary Immunodeficiency DiseasesGenetic VariationHumansT-LymphocytesHigh-Throughput Nucleotide SequencingSignal TransductionGain of Function Mutation

Stichwörter der Autor:innen

APDSCRISPR base editingVUSactivated PI3K delta syndromeclinical NGSgenome engineeringinborn errors of immunityprecision medicineprimary T cellsvariant classification

Substanzen

Class I Phosphatidylinositol 3-KinasesClass Ia Phosphatidylinositol 3-KinasePIK3R1 protein, humanPIK3CD protein, human

Autor:innen und Institutionen

  • Columbia University Vagelos College of Physicians and Surgeons, New York, NY, USA; Department of Medicine, Division of Hematology and Oncology, Columbia University Irving Medical Center, New York, NY, USA; Columbia Cent…
  • Department of Pediatrics, Columbia University Irving Medical Center, New York, NY.
  • Department of Medicine, Division of Hematology and Oncology, Columbia University Irving Medical Center, New York, NY, USA; Columbia Center for Translational Immunology, New York, NY, USA; Herbert Irving Comprehensive Ca…
  • Columbia University Vagelos College of Physicians and Surgeons, New York, NY, USA.
  • Department of Pediatrics, Columbia University Irving Medical Center, New York, NY. Electronic address: jdm2249@cumc.columbia.edu.

Förderung

  • NCI NIH HHS
  • NIAID NIH HHS
  • NIGMS NIH HHS
  • Herbert Irving Comprehensive Cancer Center, Columbia University
  • Cancer Research Institute
  • Melanoma Research Foundation
  • Burroughs Wellcome Fund
  • National Cancer Institute

Zitieren

APA

Walsh, Z. H., Frangieh, C. J., Kothapalli, N., Levy, J., Heck, C. K., Melms, J. C., Gejman, R. S., Shah, P., Pollard, J. M., Naik, A., Grauman, S. L., Huang, L. H., Lee, A., Bogunovic, D., Milner, J. D., & Izar, B. (2025). Scalable generation and functional classification of genetic variants in inborn errors of immunity to accelerate clinical diagnosis and treatment. Cell. https://doi.org/10.1016/j.cell.2025.05.037

Vancouver

Walsh ZH, Frangieh CJ, Kothapalli N, Levy J, Heck CK, Melms JC, et al. Scalable generation and functional classification of genetic variants in inborn errors of immunity to accelerate clinical diagnosis and treatment. Cell. 2025. doi:10.1016/j.cell.2025.05.037

BibTeX
@article{Walsh2025,
  author = {Walsh, Zachary H and Frangieh, Chris J and Kothapalli, Neeharika and Levy, Jay and Heck, Clarissa K and Melms, Johannes C and Gejman, Ron S and Shah, Parin and Pollard, Jared M and Naik, Akul and Grauman, Sarah L and Huang, Lei Haley and Lee, Ashley and Bogunovic, Dusan and Milner, Joshua D and Izar, Benjamin},
  title = {Scalable generation and functional classification of genetic variants in inborn errors of immunity to accelerate clinical diagnosis and treatment},
  journal = {Cell},
  year = {2025},
  doi = {10.1016/j.cell.2025.05.037}
}
Kostenlos starten →